Skip to main content

Vanda Pharmaceuticals(VNDA-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Vanda Pharmaceuticals

2200 PENNSYLVANIA AVENUE NW SUITE 300E
WASHINGTON DC 20037 USA
P: 202-734-3400
F: 202-296-1450
http://www.vandapharma.com

Profile

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders. It is developing important new medicines to improve the lives of patients. It uses new technologies, including genetics & genomics, to inform our drug discovery, our clinical trials, and our commercial positioning of our compounds. The Company has three product candidates in clinical development. It's lead product candidate, iloperidone, is a compound for the treatment of schizophrenia & bipolar disorder & is in a Phase III clinical trial for schizophrenia. It's second product candidate, is a compound for the treatment of insomnia & depression which is currently in a Phase III clinical trial for insomnia. It's third product candidate, is a compound for the treatment of excessive sleepiness & is ready for a Phase II clinical trial.

Key Executives

NameTitle
Mihael Hristos PolymeropoulosCEO/Chairman of the Board/Co-Founder/Director/President
Kevin MoranCFO/Chief Accounting Officer/Senior VP/Treasurer

More from The Globe

Wednesday’s analyst upgrades and downgrades
An office building for Goeasy Ltd, a personal lender for subprime borrowers, in Mississauga, Ontario, on March 10, 2026.
Bullish on Archer-Daniels-Midland Co.
Monica Rizk
Constellation ‘well-positioned’ to tackle AI disruption in software industry, company president says
In this photo illustration, a mobile phone with the logo of Canadian company Constellation Software Inc. is seen in front of business website.
number cruncher
Eight telecom stocks to watch during volatile times
For Number Cruncher column in Globe Investor/ROB only.
The most oversold and overbought stocks on the TSX
The TMX Market Centre is shown in Toronto, Wednesday, Sept. 11, 2024.
Analysts’ forecast returns, recommendations and yields for all stocks in the S&P/TSX SmallCap Index
The S&P TSX composite index screen at the TMX Market Centre in Toronto is photographed on Friday, November 11, 2022.
Small caps to watch: Aecon, Maple Leaf Foods, Tecsys and more
Packages of Maple Leaf Foods chicken breasts are shown on a shelf at a grocery store in Oakville, Ont., Friday, Jan.6, 2023.
Thursday’s analyst upgrades and downgrades
A pumpjack operates at the Vermilion Energy site in Trigueres, France, June 14, 2024.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.